UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 27, 2026
Accession Number: 0001213900-26-007469
Submission Type: POS AM
CIK: 0001841330
Company Name: Pasithea Therapeutics Corp.
File Number: 333-271010